A longitudinal analysis on associations of adiponectin levels with metabolic syndrome and carotid artery intima-media thickness. The Cardiovascular Risk in Young Finns Study

Atherosclerosis

Volumn 217, Issue 1, 2011, Pages 234-239

  Juonala, Markus ^a,b   Saarikoski, Liisa A ^a,b   Viikari, Jorma S A ^b   Oikonen, Mervi ^a   Lehtimäki, Terho ^c   Lyytikäinen, Leo Pekka ^c   Huupponen, Risto ^b   Magnussen, Costan G ^a,d   Koskinen, Juha ^a   Laitinen, Tomi ^e   Taittonen, Leena ^f   Kähönen, Mika ^c   Kivimäki, Mika ^g   Raitakari, Olli T ^b  

^a UNIVERSITY OF TURKU   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^d MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^e UNIVERSITY OF EASTERN FINLAND   (Finland)

^f VAASA CENTRAL HOSPITAL   (Finland)

^g UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Adiponectin; Atherosclerosis; Intima media thickness; Metabolic syndrome

Indexed keywords

ADIPONECTIN; APOLIPOPROTEIN B; C REACTIVE PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ABDOMINAL OBESITY; ADULT; ARTERIAL WALL THICKNESS; ARTERY INTIMA; ARTERY MEDIA; ARTICLE; ATHEROGENESIS; BODY MASS; CARDIOVASCULAR RISK; CAROTID ARTERY; CAROTID ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FAMILY HISTORY; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HORMONE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; INSULIN BLOOD LEVEL; INTIMA MEDIA THICKNESS; LIPOPROTEIN BLOOD LEVEL; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; POPULATION RESEARCH; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SMOKING; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADIPONECTIN; ADOLESCENT; ADULT; CAROTID ARTERIES; CAROTID ARTERY DISEASES; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; FINLAND; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; MALE; METABOLIC SYNDROME X; MULTIVARIATE ANALYSIS; ODDS RATIO; TUNICA INTIMA; TUNICA MEDIA;

EID: 79960242991     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2011.03.016     Document Type: Article

References (30)

1. Lakka H.-M., Laaksonen D.E., Lakka T.A., et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002, 288:2709-2716.
2. Sniderman A.D., Faraj M. Apolipoprotein B, apolipoprotein A-I, insulin resistance and the metabolic syndrome. Curr Opin Lipidol 2007, 18:633-637.
3. Scherer P.E., Williams S., Fogliano M., et al. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 1995, 270:26746-26749.
4. Maury E., Brichard S.M. Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Mol Cell Endocrinol 2010, 314:1-16.
5. Arita Y., Kihara S., Ouchi N., et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999, 257:79-83.
6. Pischon T., Girman C.J., Hotamisligil G.S., et al. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 2004, 291:1730-1737.
7. Pilz S., Horejsi R., Möller R., et al. Early atherosclerosis in obese juveniles is associated with low serum levels of adiponectin. J Clin Endocrinol Metab 2005, 90:4792-4796.
8. Saarikoski L.A., Huupponen R.K., Viikari J.S., et al. Adiponectin is related with carotid artery intima-media thickness and brachial flow-mediated dilatation in young adults - the Cardiovascular Risk in Young Finns Study. Ann Med 2010, Sep 14 [Epub ahead of print].
9. Langenberg C., Bergström J., Scheidt-Nave C., et al. Cardiovascular death and the metabolic syndrome: role of adiposity-signaling hormones and inflammatory markers. Diab Care 2006, 29:1363-1369.
10. Bahia L., Aguair L.G., Villela N., et al. Adiponectin is associated with improvement of endothelial function after rosiglitazone treatment in non-diabetic individuals with metabolic syndrome. Atherosclerosis 2007, 195:138-146.
11. Raiko J.R.H., Viikari J.S.A., Ilmanen A., et al. Follow-ups of the Cardiovascular Risk in Young Finns Study in 2001 and 2007: levels and 6-year changes in risk factors. J Intern Med 2010, 267:370-384.
12. Juonala M., Kähönen M., Laitinen T., et al. Effect of age and sex on carotid intima-media thickness, elasticity and brachial endothelial function in healthy adults: the Cardiovascular Risk in Young Finns Study. Eur Heart J 2008, 29:1198-1206.
13. Alberti K.G., Eckel R.H., Grundy S.M., et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009, 120:1640-1645.
14. Ryo M., Nakamura T., Kihara S., et al. Adiponectin as a biomarker of the metabolic syndrome. Circ J 2004, 68:975-981.
15. Hara K., Horikoshi M., Yamauchi T., et al. Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome. Diab Care 2006, 29:1357-1362.
16. Beauloye V., Zech F., Mong T.T., et al. Determinants of early atherosclerosis in obese children and adolescents. J Clin Endocrinol Metab 2007, 92:3025-3032.
17. Seino Y., HIrose H., Saito I., et al. High-molecular-weight adiponectin is a predictor of progression to metabolic syndrome: a population-based 6-year follow-up study in Japanese men. Metabolism 2009, 58:355-360.
18. Kadowaki T., Yamauchi T., Kubota N., et al. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 2006, 116:1784-1792.
19. Lara-Castro C., Luo N., Wallace P., et al. Adiponectin multimeric complexes and the metabolic syndrome trait cluster. Diabetes 2006, 55:249-259.
20. Dyck D.J. Adipokines as regulators of muscle metabolism and insulin sensitivity. Appl Physiol, Nutr Metab 2009, 34:396-402.
21. Kowalska I., Straczkowski M., Nikolajuk A., et al. Insulin resistance, serum adiponectin, and proinflammatory markers in young subjects with the metabolic syndrome. Metab Clin Exp 2008, 57:1539-1544.
22. Wang Z., Nakayama T. Inflammation, a link between obesity and cardiovascular disease. Mediators Inflamm 2010.
23. Okamoto Y., Kihara S., Funahashi T., et al. Adiponectin: a key adipocytokine in metabolic syndrome. Clin Sci 2006, 110:267-278.
24. Yamauchi T., Nio Y., Maki T., et al. Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nat Med 2007, 13:332-339.
25. Mattsson N., Rönnemaa T., Juonala M., et al. Arterial structure and function in young adults with the metabolic syndrome: the Cardiovascular Risk in Young Finns Study. Eur Heart J 2008, 29:784-791.
26. Koskinen J., Kähönen M., Viikari J.S., et al. Conventional cardiovascular risk factors and metabolic syndrome in predicting carotid intima-media thickness progression in young adults: the Cardiovascular Risk in Young Finns Study. Circulation 2009, 120:229-236.
27. Wannamethee S.G., Whincup P.H., Lennon L., et al. Circulating adiponectin levels and mortality in elderly men with and without cardiovascular disease and heart failure. Arch Intern Med 2007, 167:1510-1517.
28. Laughlin G.A., Barrett-Connor E., May S., et al. Association of adiponectin with coronary heart disease and mortality: the Rancho Bernardo study. Am J Epidemiol 2007, 165:164-174.
29. Dieplinger B., Haltmayer M., Poelz W., et al. Value of adiponectin as predictor of 5-year all-cause mortality in patients with symptomatic peripheral arterial disease: results from the Linz Peripheral Arterial Disease (LIPAD) study. Clin Chim Acta 2009, 408:87-91.
30. Koskinen J., Magnussen C.G., Taittonen L., et al. Arterial structure and function after recovery from the metabolic syndrome: the Cardiovascular risk in Young Finns Study. Circulation 2010, 121:392-400.